Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Oncology

Part 3: Nancy Simonian, MD on the Future of Super-Enhancers

What is the Therapeutic Approach for Super-Enhancers?

Nancy Simonian, MD, CEO, Syros Pharmaceuticals explains that by modulating components of super-enhancers, important genes that drive disease states may be able to be turned down. She references a recent study published in Cell that indicated a chromatin...
The Associated Press reports on new findings published in JAMA Internal Medicine that have shown that lung tumors may be over-detected by CT scans. Researchers “used data from the National Lung Screening Trial (NLST), a randomized trial comparing...

Part 2: Anti-Cancer Potential of Cannabinoids

What Effect Do Cannabinoids Have on Tumors?

Martin Lee, author of Smoke Signals, and director of Project CBD, discusses the enlightening research coming out of the California Pacific Medical Center about the antitumor and anticancer effects of cannabinoids. Cannabidiol, in particular, has been...